Univariate analyses identified comorbidity prevalence, age, region, administration mode, and language as significant contributors
Recipient food intake during refeeding was then measured, but no significant difference was observed between the control and liraglutide-treated groups (Supplementary Fig
Wespers platform enables primary care providers to accurately diagnose and monitor sleep disorders at home, while the recent FDA approval of Zepbound opens new doors for managing obesity and sleep apnea together
Semaglutide GLP-1 works by regulating appetite and improving insulin sensitivity, but its full effects typically become evident after several weeks of use
Dual- and triple-receptor agonists acting via different receptors and postreceptor pathways seem attractive in view of potentially additive or synergistic effects in the treatment of T2D and obesity
A prescriber may write a prescription in Units or in mLs